We are live on
!
Find out more
BHCM
Brevan Howard Capital Management Portfolio holdings
AUM
$11.3B
1-Year Est. Return
35.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.05%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$9.16B
AUM Growth
-$13.2B
(-59%)
Cap. Flow
-$10.8B
Cap. Flow
% of AUM
-117.92%
Top 10 Holdings %
Top 10 Hldgs %
34.38%
Holding
2,371
New
451
Increased
532
Reduced
695
Closed
657
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTKI
First Trust Small Cap BuyWrite Income ETF
FTKI
|
+$1.07B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$111M |
| 3 |
Walmart Inc
WMT
|
+$84M |
| 4 |
Oracle
ORCL
|
+$58.3M |
| 5 |
Broadcom
AVGO
|
+$57.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$1.77B |
| 2 |
Microsoft
MSFT
|
+$184M |
| 3 |
Meta Platforms (Facebook)
META
|
+$128M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$68.8M |
| 5 |
Comfort Systems
FIX
|
+$42.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.09% |
| 2 | Financials | 7.11% |
| 3 | Healthcare | 5.24% |
| 4 | Communication Services | 5.21% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
KRONOS Worldwide
KRO
$977M
| $97.4K | ﹤0.01% |
+22,035
| New | +$107K |
|
1652
Allogene Therapeutics
ALLO
$725M
| $96.5K | ﹤0.01% |
+70,429
| New | +$92.9K |
|
1653
Enovix
ENVX
$1.01B
| $95.3K | ﹤0.01% |
13,039
-7,554
| -37% | -$73.2K |
|
1654
Ginkgo Bioworks
DNA
$515M
| $94.7K | ﹤0.01% |
+11,401
| New | +$123K |
|
1655
American Express Global Business Travel
GBTG
$4.94B
| $90K | ﹤0.01% |
11,760
-15,735
| -57% | -$122K |
|
1656
Vermilion Energy
VET
$1.75B
| $84.9K | ﹤0.01% |
+10,185
| New | +$84.1K |
|
1657
Portillo's
PTLO
$325M
| $82.9K | ﹤0.01% |
18,256
-216,079
| -92% | -$1.13M |
|
|
CMRC
1658
Commerce.com Inc Series 1
CMRC
$175M
| $82.7K | ﹤0.01% |
20,080
-23,471
| -54% | -$108K |
|
1659
Gogo Inc
GOGO
$432M
| $78.2K | ﹤0.01% |
+16,788
| New | +$123K |
|
1660
Health Catalyst
HCAT
$129M
| $75.6K | ﹤0.01% |
+31,633
| New | +$86.5K |
|
|
EEX
1661
DELISTED
Emerald Holding
EEX
| $74.7K | ﹤0.01% |
+16,719
| New | +$72K |
|
1662
Inogen
INGN
$160M
| $70.3K | ﹤0.01% |
10,460
-13,753
| -57% | -$103K |
|
1663
Xerox
XRX
$427M
| $66.4K | ﹤0.01% |
28,033
-292,127
| -91% | -$865K |
|
1664
Hyliion Holdings
HYLN
$701M
| $65.4K | ﹤0.01% |
+35,556
| New | +$71.6K |
|
1665
indie Semiconductor
INDI
$786M
| $64.3K | ﹤0.01% |
18,216
-124,779
| -87% | -$547K |
|
1666
OraSure Technologies
OSUR
$276M
| $64.1K | ﹤0.01% |
+26,496
| New | +$69.7K |
|
1667
Babcock & Wilcox
BW
$1.32B
| $64K | ﹤0.01% |
+10,091
| New | +$49.8K |
|
1668
The Honest Company
HNST
$561M
| $62.5K | ﹤0.01% |
24,235
-118,126
| -83% | -$362K |
|
1669
Digital Turbine
APPS
$1.74B
| $60.2K | ﹤0.01% |
12,043
-10,035
| -45% | -$56.8K |
|
1670
Clean Energy Fuels
CLNE
$355M
| $59.2K | ﹤0.01% |
+28,188
| New | +$69K |
|
1671
Geron
GERN
$949M
| $58.9K | ﹤0.01% |
44,613
-224,915
| -83% | -$282K |
|
|
NXDR
1672
Nextdoor Holdings
NXDR
$1.04B
| $58.8K | ﹤0.01% |
+28,012
| New | +$54.9K |
|
1673
Foghorn Therapeutics
FHTX
$371M
| $56.6K | ﹤0.01% |
+10,486
| New | +$47.5K |
|
1674
Ribbon Communications
RBBN
$367M
| $52.5K | ﹤0.01% |
18,219
+2,720
| +18% | +$8.78K |
|
1675
Gevo
GEVO
$388M
| $51.2K | ﹤0.01% |
25,600
-39,246
| -61% | -$86.4K |
|
Similar funds
GKIM
DCP
VLKIM
ERSOT
DWM
HTC
BCI
Brevan Howard Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Brevan Howard Capital Management held 2,371 positions worth $9.16B, down 59% from $22.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Brevan Howard Capital Management withdrew a net $10.8B in Q4 2025, closing 657 positions and reducing 695 holdings. Its most notable exit was Insmed, an estimated $42.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 4.4% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Brevan Howard Capital Management opened a new position in First Trust Small Cap BuyWrite Income ETF worth $452M.
- Brevan Howard Capital Management's largest Q4 2025 buy was First Trust Small Cap BuyWrite Income ETF: 57,081,120 shares worth $452M.
- Brevan Howard Capital Management added most to Walmart Inc in Q4 2025, an estimated $84M increase.
- Brevan Howard Capital Management's biggest Q4 2025 reduction was iShares Bitcoin Trust, cutting an estimated $1.77B.
- Brevan Howard Capital Management fully exited Insmed in Q4 2025, selling an estimated $42.3M.
- Brevan Howard Capital Management's ten largest holdings make up 34% of its $9.16B portfolio in Q4 2025.
- Brevan Howard Capital Management opened 451 new positions and closed 657 in Q4 2025.
- Brevan Howard Capital Management's portfolio value fell 59% quarter-over-quarter to $9.16B.
Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.